|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/76 | |
| A61K 35/765 | |||
| A61K 35/768 | |||
| A61P 35/00 | |||
| A61K 31/337 | |||
| A61K 31/555 |
| (11) | Number of the document | 3068411 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14861625.3 |
| Date of filing the European patent application | 2014-11-12 | |
| (97) | Date of publication of the European application | 2016-09-21 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CA2014/000806 |
| Date | 2014-11-12 |
| (87) | Number | WO 2015/070323 |
| Date | 2015-05-21 |
| (30) | Number | Date | Country code |
| 201361904783 P | 2013-11-15 | US |
| (72) |
COFFEY, Matthew C., CA
THOMPSON, Bradley G., CA
|
| (73) |
Oncolytics Biotech Inc.,
Suite 210 1167 Kensington Crescent N. W., Calgary, AB T2N 1X7,
CA
|
| (54) | ONCOLYTIC VIRUSES AND INCREASED CANCER TREATMENT REGIMENS |
| ONCOLYTIC VIRUSES AND INCREASED CANCER TREATMENT REGIMENS |